Francesco C. Stingo

Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemia

Philip A. Thompson, Constantine S. Tam, Susan O’Brien et al. · Blood · 2015 · 503 citations · Full text

Medicine, Immunology, Oncology +12

Delta-radiomics features for the prediction of patient outcomes in non–small cell lung cancer

Xenia Fave, Lifei Zhang, Jinzhong Yang et al. · Scientific Reports · 2017 · 348 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib‐based regimens

Philip A. Thompson, Susan O’Brien, William G. Wierda et al. · Cancer · 2015 · 247 citations · Full text

Life Sciences, Immunology, Oncology +13

Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms

Sa A. Wang, Robert P. Hasserjian, Patricia S. Fox et al. · Blood · 2014 · 205 citations · Full text

Medicine, Hematology, Oncology +14

Bayesian Inference of Multiple Gaussian Graphical Models

Christine B. Peterson, Francesco C. Stingo, Marina Vannucci · Journal of the American Statistical Association · 2014 · 205 citations

Life Sciences, Bioinformatics, Cancer Biology +16